Sofinnova Crossover II S.L.P.

Overview

• HeadquartersI0¹

See how the biggest companies compare on our leaderboards

Corporate structure

Sofinnova Crossover II S.L.P. sits at the top of its group. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.

Stakes it holds

Sofinnova Crossover II S.L.P. has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).

• Hemab Therapeutics Holdings, Inc.SCHEDULE 13G Aug 5, 2026²